Emmanuel Biver

Summary

Country: France

Publications

  1. doi request reprint Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis
    Emmanuel Biver
    Department of Rheumatology, Roger Salengro Hospital, University Hospital of Lille, Rue Emile Laine, 59037 Lille Cedex, France
    J Clin Endocrinol Metab 96:2703-13. 2011
  2. doi request reprint Use of bone turnover markers in clinical practice
    Emmanuel Biver
    Department of Rheumatology, Lille University Hospital, Roger Salengro Hospital, Lille Cedex, France
    Curr Opin Endocrinol Diabetes Obes 19:468-73. 2012
  3. doi request reprint The "bone morphogenic proteins" pathways in bone and joint diseases: translational perspectives from physiopathology to therapeutic targets
    Emmanuel Biver
    Physiopathology of Inflammatory Bone Diseases, EA 4490, University Lille North of France, Quai Masset, Bassin Napoleon, BP120, 62327 Boulogne sur Mer, France
    Cytokine Growth Factor Rev 24:69-81. 2013
  4. doi request reprint Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells
    Emmanuel Biver
    Physiopathology of Inflammatory Bone Diseases, EA 4490, University Lille North of France, Quai Masset, Bassin Napoleon, BP120, 62327 Boulogne sur Mer, France
    Biochem Biophys Res Commun 427:737-42. 2012
  5. doi request reprint Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis
    Emmanuel Biver
    Department of Rheumatology, Roger Salengro Hospital, CHRU de Lille, University Lille Nord de France, 59037 Lille Cedex, France
    Joint Bone Spine 79:20-5. 2012
  6. doi request reprint Low and stable prevalence of rheumatoid arthritis in northern France
    Emmanuel Biver
    Service de Rhumatologie, CHRU de Lille, Universite de Lille 2, 59037 Lille Cedex, France
    Joint Bone Spine 76:497-500. 2009
  7. doi request reprint No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site
    E Biver
    Department of Rheumatology, CHRU Lille, University Lille Nord de France, 59037 Lille, France
    Bone 46:643-8. 2010
  8. doi request reprint Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis
    Florence Chopin
    Inserm U1059, Department of Rheumatology, University Hospital of Saint Etienne, 42055 Saint Etienne Cedex 2, France
    Joint Bone Spine 79:26-31. 2012
  9. doi request reprint Changes in the incidence and management of spinal tuberculosis in a French university hospital rheumatology department from 1966 to 2010
    Cécile Wibaux
    Service de Rhumatologie, Universite de Lille 2, Hopital Roger Salengro, CHRU de Lille, Rue Emile Laine, 59037 Lille Cedex, France Electronic address
    Joint Bone Spine 80:516-9. 2013
  10. doi request reprint Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation
    Joseph Caverzasio
    Service of Bone Diseases, Department of Internal Medicine Specialties, University Hospital of Geneva, Geneva, Switzerland
    J Bone Miner Res 28:260-70. 2013

Detail Information

Publications10

  1. doi request reprint Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis
    Emmanuel Biver
    Department of Rheumatology, Roger Salengro Hospital, University Hospital of Lille, Rue Emile Laine, 59037 Lille Cedex, France
    J Clin Endocrinol Metab 96:2703-13. 2011
    ..Adipokines (leptin, adiponectin, resistin, visfatin) and ghrelin may be implicated in bone metabolism...
  2. doi request reprint Use of bone turnover markers in clinical practice
    Emmanuel Biver
    Department of Rheumatology, Lille University Hospital, Roger Salengro Hospital, Lille Cedex, France
    Curr Opin Endocrinol Diabetes Obes 19:468-73. 2012
    ..To describe the modalities and interest of the use of bone turnover markers (BTMs) in clinical practice for osteoporosis management...
  3. doi request reprint The "bone morphogenic proteins" pathways in bone and joint diseases: translational perspectives from physiopathology to therapeutic targets
    Emmanuel Biver
    Physiopathology of Inflammatory Bone Diseases, EA 4490, University Lille North of France, Quai Masset, Bassin Napoleon, BP120, 62327 Boulogne sur Mer, France
    Cytokine Growth Factor Rev 24:69-81. 2013
    ..The use of recombinant BMPs in bone tissue engineering and in the treatment of skeletal diseases, or future therapeutic strategies targeting BMPs signal and its regulators, will be discussed based on these considerations...
  4. doi request reprint Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells
    Emmanuel Biver
    Physiopathology of Inflammatory Bone Diseases, EA 4490, University Lille North of France, Quai Masset, Bassin Napoleon, BP120, 62327 Boulogne sur Mer, France
    Biochem Biophys Res Commun 427:737-42. 2012
    ..These crosstalks between growth and osteogenic factors should be considered in the use of recombinant BMPs in therapeutic purpose of fracture repair or skeletal bioengineering...
  5. doi request reprint Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis
    Emmanuel Biver
    Department of Rheumatology, Roger Salengro Hospital, CHRU de Lille, University Lille Nord de France, 59037 Lille Cedex, France
    Joint Bone Spine 79:20-5. 2012
    ..Their interest for the positive and etiological diagnosis of osteoporosis at baseline, and their predictive value for past asymptomatic vertebral fractures, were evaluated by a systematic review of the literature...
  6. doi request reprint Low and stable prevalence of rheumatoid arthritis in northern France
    Emmanuel Biver
    Service de Rhumatologie, CHRU de Lille, Universite de Lille 2, 59037 Lille Cedex, France
    Joint Bone Spine 76:497-500. 2009
    ..13%) than nationwide (0.31%) or in southern France (0.66%). Here, our objective was to confirm the lower prevalence of RA in northern France than in the rest of the country or in Europe...
  7. doi request reprint No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site
    E Biver
    Department of Rheumatology, CHRU Lille, University Lille Nord de France, 59037 Lille, France
    Bone 46:643-8. 2010
    ..Zoledronic acid is currently administered in osteoporotic patients as a single 5 mg injection once a year and its vascular effect in bone has not been yet evaluated...
  8. doi request reprint Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis
    Florence Chopin
    Inserm U1059, Department of Rheumatology, University Hospital of Saint Etienne, 42055 Saint Etienne Cedex 2, France
    Joint Bone Spine 79:26-31. 2012
    ..The aim was to review the literature dealing with the use of biochemical bone turnover markers (BTM) as predictors of bone loss and individual risk of fracture in postmenopausal osteoporosis...
  9. doi request reprint Changes in the incidence and management of spinal tuberculosis in a French university hospital rheumatology department from 1966 to 2010
    Cécile Wibaux
    Service de Rhumatologie, Universite de Lille 2, Hopital Roger Salengro, CHRU de Lille, Rue Emile Laine, 59037 Lille Cedex, France Electronic address
    Joint Bone Spine 80:516-9. 2013
    ..We also compared patients seen between 1966 and 1995 to those seen between 1995 and 2010...
  10. doi request reprint Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation
    Joseph Caverzasio
    Service of Bone Diseases, Department of Internal Medicine Specialties, University Hospital of Geneva, Geneva, Switzerland
    J Bone Miner Res 28:260-70. 2013
    ....